DXCM logo

DexCom Inc (DXCM)

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system;...

NASDAQHealthcareMedical DevicesUSA

公司簡介

股票程式碼
DXCM
ISIN程式碼
US2521311074
貨幣
US Dollar (USD)
IPO日期
2005-04-14

聯絡資訊

公司地址
6340 Sequence Drive, San Diego, CA, United States, 92121
聯絡電話
858 200 0200
公司網站
https://www.dexcom.com
財年結束
December

財務亮點

市值
$999,999.99
毛利潤(TTM)
$999,999.99
資產回報率(TTM)
9.65%
EBITDA
$999,999.99
收入(TTM)
$999,999.99